Therefore, the abnormal overexpression of oncogenic miRNAs in ER+ breast cancer attenuates PTEN-mediated inhibition of PI3K/Akt signaling, which in turn increases oncogenic cell growth, survival, and migration through downstream Akt signaling (33). The gene discussed is PTEN; the disease is breast cancer.